112 related articles for article (PubMed ID: 7192862)
1. [Endocrine effect of L-DOPA in treating the amenorrhea-galactorrhea syndrome].
Koreneva GP; Shikaeva FV
Probl Endokrinol (Mosk); 1980; 26(6):25-8. PubMed ID: 7192862
[TBL] [Abstract][Full Text] [Related]
2. [Syndrome of amenorrhea and galactorrhea associated with sterility. Treatment with levodopa].
García Núñez R; Fierro Villarreal OH; Thomas del Río G; Iduñate y Carlos DM; Hernández Ayup S
Ginecol Obstet Mex; 1980 Oct; 48(288):255-9. PubMed ID: 7215900
[No Abstract] [Full Text] [Related]
3. Restoration of ovarian function in patients with the amenorrhea-galactorrhea syndrome after long-term therapy with L-dopa.
Zárate A; Canales ES; Jacobs LS; Maneiro PJ; Soria J; Daughaday WH
Fertil Steril; 1973 May; 24(5):340-4. PubMed ID: 4735421
[No Abstract] [Full Text] [Related]
4. Effect of L-dopa on galactopoiesis and gonadotropin levels in the inappropriate lactation syndrome.
Ayalon D; Peyser MR; Toaff R; Cordova T; Harell A; Franchimont P; Lindner HR
Obstet Gynecol; 1974 Aug; 44(2):159-70. PubMed ID: 4418555
[No Abstract] [Full Text] [Related]
5. [Use of clomiphene for treating lactorrhea and amenorrhea].
Pishchulin AA; Mel'nichenko GA
Probl Endokrinol (Mosk); 1982; 28(2):31-4. PubMed ID: 7043448
[TBL] [Abstract][Full Text] [Related]
6. [Hypothalamo-hypophyseal-gonadal axis in the galactorrhea-amenorrhea syndrome with hypophyseal tumors and other endocrine disorders].
Maleeva A; Vulkov I
Akush Ginekol (Sofiia); 1977; 16(3):182-90. PubMed ID: 561556
[No Abstract] [Full Text] [Related]
7. [Hypothalamo-hypophyseal-ovarian interrelationships in the galactorrhea-amenorrhea syndrome].
Maleeva A; Volkov I
Akush Ginekol (Mosk); 1980 Jun; (6):24-6. PubMed ID: 6773433
[No Abstract] [Full Text] [Related]
8. Nonpuerperal lactation and normal prolactin regulation.
Malarkey WB
J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhea-galactorrhea syndrome.
Zárate A; Canales ES; Soria J; Maneiro PJ; MacGregor C
Neuroendocrinology; 1973; 12(6):362-5. PubMed ID: 4796782
[No Abstract] [Full Text] [Related]
10. [Use of blockers and stimulators of prolactin secretion in the syndrome of persistent lactorrhea--amenorrhea].
Starkova NT; Mel'nichenko GA
Probl Endokrinol (Mosk); 1978; 24(6):42-7. PubMed ID: 103087
[TBL] [Abstract][Full Text] [Related]
11. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
[TBL] [Abstract][Full Text] [Related]
12. [Intermittent administration of bromocriptine in the treatment of amenorrhea-galactorrhea syndrome].
Hartemann P; Leclere J; Groussin M; Mizrahi R
Nouv Presse Med; 1977 Oct; 6(34):3111. PubMed ID: 562510
[No Abstract] [Full Text] [Related]
13. Use of blockers and stimulators of prolactin secretion in persistent lactorrhea-amenorrhea syndrome.
Starkova NT; Mel'nichenko GA
Neurosci Behav Physiol; 1980; 10(6):476-80. PubMed ID: 6783976
[No Abstract] [Full Text] [Related]
14. Hypothalamus-pituitary function in amenorrhea-galactorrhea syndrome.
Delitala G; Masala A; Alagna S; Devilla L
Panminerva Med; 1978; 20(2):89-96. PubMed ID: 212704
[No Abstract] [Full Text] [Related]
15. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
Badawy SZ; Nusbaum ML; Omar M
Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
[TBL] [Abstract][Full Text] [Related]
17. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
Boyd AE; Reighlin S
N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
[No Abstract] [Full Text] [Related]
18. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome.
Wortsman J; Soler NG; Hirschowitz J
Ann Intern Med; 1979 Jun; 90(6):923-5. PubMed ID: 571691
[TBL] [Abstract][Full Text] [Related]
19. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
20. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
